OKTA Earnings Preview: Recent $OKTA Insider Trading, Hedge Fund Activity, and More

Okta is set to release quarterly earnings on May 27th, with analysts anticipating revenue of $693.93 million and EPS of $0.79. Over the past six months, Okta insiders have sold shares, with Frederic Kerrest selling the most at $122.73 million; however, institutional investors increased positions with FMR LLC adding the most at $415.59 million, while Marshall Wace, LLP decreased their position the most at $280.66 million. Recent analyst ratings are predominantly "Buy," with a median price target of $112.50.

Analysis

Okta is poised to release its quarterly earnings on May 27th, with analyst consensus projecting revenue of $693.93 million and earnings per share of $0.79. Notably, there has been substantial insider selling activity over the past six months, characterized by 73 sales and no purchases. Key sales include those by Jacques Frederic Kerrest (1,313,230 shares for an estimated $122.73 million), CEO Todd McKinnon (467,317 shares for an estimated $45.72 million), and CFO Brett Tighe (20,000 shares for an estimated $1.83 million). In contrast, institutional activity presents a more mixed picture: 429 institutions added Okta shares while 373 reduced their positions. Significant additions were made by FMR LLC (3.95 million shares, +23.3%) and Massachusetts Financial Services Co /MA/ (2.83 million shares, +325.6%), whereas Marshall Wace, LLP (-2.67 million shares, -74.4%) and Point72 Asset Management, L.P. (-2.11 million shares, -94.4%) made substantial divestitures. Despite the insider selling and some institutional reductions, Wall Street analysts remain predominantly bullish, with eight firms issuing "Buy" or "Outperform" ratings recently and no "Sell" ratings. The median price target from ten analysts over the last six months is $112.50, with recent individual targets ranging up to $135.00 (UBS).

Key Decisions for Investors

• Investors should closely scrutinize Okta's May 27th earnings report for actual revenue and EPS figures against the guided $693.93 million and $0.79 respectively, and pay keen attention to management's forward outlook.
• The significant volume of insider sales, particularly by top executives, warrants caution and should be carefully weighed against consistently positive analyst ratings and the median price target of $112.50.
• Given the divergent institutional activity, with major funds both increasing and decreasing stakes, the upcoming earnings and subsequent market reaction may provide clearer direction on Okta's near-term trajectory.